Chronic Obstructive Pulmonary Disease (COPD)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Previous pulmonary function tests consistent with the diagnosis of COPD (FEV1/FVC 3 months; 5. Patients with the medication device Ellipta or pressure metered aerosol pMDI or soft aerosol SMI; 6. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Severe cognitive impairment, inability to understand assessments and instructions, inability to understand the nature, scope, and possible consequences of the study; 2. Chronic obstructive pulmonary disease with bronchiectasis as the main manifestation; 3. Combined with interstitial lung disease, pneumothorax, pleural effusion or pulmonary embolism; 4. Concurrent malignant tumors, with an expected survival time of less than half a year; 5. Lung volume reduction surgery within 3 months before admission 6. Serious diseases, such as heart, liver, kidney diseases or hemodynamic instability; 7. Women who are pregnant, breastfeeding, or intending to become pregnant during the course of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of exacerbations within 12 weeks post-discharge.; | — |
Secondary
| Measure | Time frame |
|---|---|
| EXACT-PRO scale score;Severity of each exacerbation within 12 weeks post-discharge;Peak inspiratory flow rate during resistive inhalation;Inhalation time (EIT). ;Inhalation volume (EIV); Inhalation flow rate assessment score. ;Inhalation operation assessment;Lung function;Six-minute walk test; | — |
Countries
China
Contacts
China-Japan Friendship Hospital